Tahseen Al-Saleem Selected Research

Tahseen Al-Saleem Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 03/2002
9	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 08/2003
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 03/2002
5	Neoplasm Metastasis (Metastasis) 09/2009 - 09/2005
4	Lymphoma (Lymphomas) 01/2013 - 03/2005
2	Disease Progression 04/2014 - 03/2014
2	Carcinogenesis 01/2013 - 12/2003
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2008 - 09/2006
2	Breast Neoplasms (Breast Cancer) 02/2008 - 09/2004
2	Carcinoma (Carcinomatosis) 09/2005 - 03/2002
1	Necrosis 01/2022
1	Melanoma (Melanoma, Malignant) 04/2014
1	Lung Neoplasms (Lung Cancer) 04/2014
1	Leukemia 05/2012
1	Lymphadenopathy 05/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2012
1	Wilms Tumor (Wilm's Tumor) 08/2010
1	Adenofibroma 08/2010
1	Extranodal NK-T-Cell Lymphoma 01/2010
1	Fanconi Anemia (Fanconi's Anemia) 02/2008
1	Ovarian Neoplasms (Ovarian Cancer) 02/2008
1	Endometrioid Carcinoma 05/2007
1	Ductal Carcinoma 05/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2006
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2006
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2006
1	Pure Red-Cell Aplasia 01/2006
1	Papillary Carcinoma 11/2005
1	Immunoproliferative Small Intestinal Disease 03/2005
1	Lobular Carcinoma 09/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2004
1	Breast Diseases (Breast Disease) 09/2004
1	Cystitis 03/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2004
1	Kidney Neoplasms (Kidney Cancer) 12/2003
1	Seizures (Absence Seizure) 03/2002
1	Cysts 03/2002
1	Tuberous Sclerosis (Bourneville's Disease) 03/2002
1	Intellectual Disability (Idiocy) 03/2002
1	Angiomyolipoma 03/2002
1	Autistic Disorder (Autism) 03/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2013 - 08/2003
5	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 12/2003
5	AndrogensIBA 09/2009 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2008
3	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2008 - 03/2004
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2004 - 12/2003
2	VimentinIBA 01/2022 - 11/2005
2	LigandsIBA 01/2021 - 04/2014
2	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2008
2	trichostatin A (A 300)IBA 09/2010 - 05/2006
2	Histones (Histone)IBA 09/2010 - 05/2006
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 09/2009 - 08/2008
2	Rituximab (Mabthera)FDA Link 09/2006 - 01/2006
2	Hematoxylin (Haematoxylon)IBA 11/2005 - 07/2004
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2005 - 07/2004
2	hydrogen sulfite (bisulfite)IBA 06/2004 - 03/2004
2	Tissue Inhibitor of Metalloproteinase-3IBA 06/2004 - 12/2003
1	HemosiderinIBA 01/2022
1	Microphthalmia-Associated Transcription FactorIBA 01/2019
1	Blocking AntibodiesIBA 04/2014
1	Indicators and Reagents (Reagents)IBA 04/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	MicroRNAs (MicroRNA)IBA 03/2014
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2013
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2013
1	Methionine (L-Methionine)FDA Link 01/2013
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 05/2012
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	pegaspargase (Oncaspar)FDA Link 01/2010
1	Cyclic AMP-Dependent Protein Kinase Type IIBA 09/2009
1	Cyclic AMP-Dependent Protein Kinase RIalpha SubunitIBA 09/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 05/2007
1	GP 4 (GP4)IBA 03/2007
1	DeoxycytidineIBA 05/2006
1	Keratin-7 (Cytokeratin 7)IBA 11/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2005
1	Death-Associated Protein KinasesIBA 09/2004
1	Cadherins (E-Cadherin)IBA 06/2004
1	Naphazoline (All Clear)FDA LinkGeneric 06/2004
1	Fumarate Hydratase (Fumarase)IBA 06/2004
1	Capsules (Microcapsules)IBA 12/2003
1	trans-sodium crocetinate (crocetin)IBA 03/2002

Therapy/Procedure

11	Radiotherapy 01/2023 - 08/2003
5	Nephrectomy 01/2020 - 07/2004
3	Therapeutics 04/2014 - 01/2006
2	Aftercare (After-Treatment) 09/2010 - 05/2006